COM:RELAYTX
Relay Therapeutics
- Stock
Last Close
4.64
22/11 21:00
Market Cap
795.07M
Beta: -
Volume Today
3.08M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | -119.03M - | -460.28M 286.68% | -335.19M 27.18% | 6.05M 101.81% | |||
average payables | 5.85M - | 6.67M 14.07% | 7.31M 9.63% | 9.43M 28.90% | 9.89M 4.96% | ||
average receivables | 41.33M - | 43.80M 5.98% | 5.08M 88.40% | 2.61M 48.63% | |||
book value per share | -44.64 - | -42.15 5.58% | 17.91 142.49% | 9.44 47.31% | 8.47 10.29% | 0.01 99.93% | |
capex per share | -0.68 - | -1.87 175.34% | -0.05 97.58% | -0.04 19.47% | -0.08 121.31% | -0.00 99.96% | |
capex to depreciation | -0.78 - | -2.81 259.13% | -0.54 80.66% | -0.88 62.53% | -2.19 148.12% | -0.78 64.31% | |
capex to operating cash flow | 0.04 - | 0.12 216.55% | 0.02 84.43% | 0.05 147.59% | 0.04 15.35% | 0.01 65.21% | |
capex to revenue | -0.02 - | -1.15 4,804.98% | -6.56 472.63% | -0.16 97.54% | |||
cash per share | 169.61 - | 83.11 51.00% | 15.91 80.86% | 17.20 8.09% | 16.45 4.35% | 0.01 99.96% | |
days of inventory on hand | |||||||
days payables outstanding | |||||||
days sales outstanding | 365 - | 595.28 63.09% | 1.38K 131.72% | ||||
debt to assets | 0.00 - | 0.06 15,112.04% | 0.03 51.67% | 0.02 25.63% | 0.05 131.21% | 0.06 20.66% | |
debt to equity | -0.00 - | -0.14 8,476.32% | 0.03 123.25% | 0.03 20.28% | 0.06 138.24% | 0.07 17.00% | |
dividend yield | |||||||
earnings yield | -0.56 - | -0.44 20.87% | -0.03 93.76% | -0.17 514.53% | -0.15 10.83% | -0.00 99.83% | |
enterprise value | -334.22M - | 132.93M 139.77% | 1.35B 914.08% | 1.99B 47.36% | 735.60M 62.97% | 1.35T 183,353.59% | |
enterprise value over ebitda | 7.17 - | -1.64 122.84% | -25.80 1,476.10% | -22.24 13.80% | -2.28 89.75% | -3.55K 155,421.11% | |
ev to operating cash flow | 7.57 - | -2.01 126.54% | -13.15 554.35% | -26.70 102.98% | -3.21 87.99% | -4.49K 140,088.21% | |
ev to sales | 16.31 - | 655.82 3,921.08% | 532.65 18.78% | 52.83K 9,817.38% | |||
free cash flow per share | -18.44 - | -17.32 6.08% | -2.45 85.85% | -0.82 66.59% | -2.13 159.66% | -0.00 99.88% | |
free cash flow yield | -0.53 - | -0.49 6.08% | -0.06 88.07% | -0.03 54.79% | -0.14 433.74% | -0.00 99.84% | |
graham net net | -47.50 - | -50.85 7.06% | 13.71 126.97% | 12.49 8.96% | 15.20 21.77% | 0.01 99.96% | |
graham number | 140.41 - | 121.37 13.56% | 21.53 82.26% | 33.30 54.69% | 20.77 37.61% | 0.02 99.91% | |
income quality | 0.90 - | 0.88 2.93% | 1.96 122.67% | 0.20 89.54% | 0.79 286.32% | 0.88 11.17% | |
intangibles to total assets | 0 - | 0 | 0 | 0.00 Infinity% | 0.00 8.30% | 0.00 30.31% | |
interest coverage | 34.14 - | ||||||
interest debt per share | 0.07 - | 5.80 7,998.12% | 0.57 90.12% | 0.24 57.99% | 0.44 81.29% | 0.00 99.90% | |
inventory turnover | |||||||
invested capital | -0.00 - | -0.14 8,476.32% | 0.03 123.25% | 0.03 20.28% | 0.06 138.24% | 0.07 17.00% | |
market cap | 87.10M - | 150.05M 72.27% | 1.77B 1,080.41% | 2.92B 64.95% | 1.68B 42.61% | 1.35T 80,386.10% | |
net current asset value | -115.44M - | -212.97M 84.49% | 733.56M 444.44% | 865.61M 18.00% | 869.95M 0.50% | 678.13M 22.05% | |
net debt to ebitda | 9.04 - | 0.21 97.67% | 8.10 3,741.73% | 10.47 29.26% | 2.92 72.14% | 0.24 91.87% | |
net income per share | -19.63 - | -15.53 20.87% | -1.15 92.60% | -5.22 354.10% | -2.27 56.62% | -0.00 99.88% | |
operating cash flow per share | -17.76 - | -15.45 13.02% | -2.40 84.43% | -0.78 67.48% | -2.04 161.45% | -0.00 99.88% | |
payables turnover | |||||||
receivables turnover | 1 - | 0.61 38.68% | 0.26 56.84% | ||||
research and ddevelopement to revenue | 1.21 - | 57.00 4,617.71% | 178.39 212.97% | 12.92 92.76% | |||
return on tangible assets | -0.11 - | -0.17 48.65% | -0.06 63.78% | -0.49 705.79% | -0.23 53.08% | -0.41 75.37% | |
revenue per share | 1.94 - | 0.03 98.36% | 0.01 61.35% | 0.00 98.31% | |||
roe | 0.44 - | 0.37 16.19% | -0.06 117.42% | -0.55 761.78% | -0.27 51.64% | -0.45 69.95% | |
roic | 0.46 - | 0.57 23.01% | -0.06 111.32% | -0.53 721.37% | -0.25 53.42% | -0.39 57.33% | |
sales general and administrative to revenue | 0.47 - | 18.95 3,958.06% | 47.78 152.17% | 2.93 93.86% | |||
shareholders equity per share | -44.64 - | -42.15 5.58% | 17.91 142.49% | 9.44 47.31% | 8.47 10.29% | 0.01 99.93% | |
stock based compensation to revenue | 0.39 - | 16.00 4,037.02% | 40.65 154.12% | 3.37 91.72% | |||
tangible asset value | -110.93M - | -180.44M 62.66% | 763.29M 523.02% | 895.51M 17.32% | 947.92M 5.85% | 749.70M 20.91% | |
tangible book value per share | -44.64 - | -42.15 5.58% | 17.91 142.49% | 9.41 47.44% | 8.45 10.27% | 0.01 99.93% | |
working capital | 417.24M - | 348.55M 16.46% | 756.47M 117.03% | 951.92M 25.84% | 955.80M 0.41% | 739.83M 22.59% |
All numbers in (except ratios and percentages)